Case Report

Cytopathologic, Histopathologic, and Immunohistochemical Features of Intrahepatic Clear Cell Bile Duct Adenoma: A Case Report and Review of the Literature

Table 1

Clinicopathologic and immunohistochemical characteristics of reported cases of intrahepatic clear cell bile duct adenoma and clear cell cholangiocarcinoma.

Case number Reference Age (y)/
gender
Size (cm) Follow-upImmunohistochemistry
CK7CK20EMApCEACD10CD56Ca 19-9VimentinKi-67p53

Intrahepatic clear cell bile duct adenoma
1Albores-Saavedra
et al. (2001) [2]
50/M0.8*Alive, 2 years+++ (cytoplasmic)ndndnd <10% in
2 of 3
cases
+ (>50%)
2Albores-Saavedra
et al. (2001) [2]
63/M0.9Alive, 2 months+++ (cytoplasmic)ndndnd+ (>50%)
3Albores-Saavedra
et al. (2001) [2]
25/F1.1Alive, 18 years+++ (cytoplasmic)ndndnd+ (>50%)
4Current case37/F2.8Alive, 19 months++++ (focal)++ (membrane)<2%+ (>50%)

Intrahepatic clear cell cholangiocarcinoma
1Logani and Adsay (1998) [9]64/F12.0ndndndndndndndndndnd
2Adamek et al. (1998) [10]62/M5.0Died, 14 months+nd+ndndndndndndnd
3Tihan et al. (1998) [11]72/M15.0Alive, 30 months++ (focal)ndndndndnd
4Falta et al. (1999) [23]50/M1.5Alive, 12 months++ndndnd+ (focal)ndnd
5Albores-Saavedra
et al. (2001) [2]
64/M6.0Alive, 3 years+ (>50%)nd+ (>50%)ndndndnd>50%+ (>50%)
6Haas et al. (2007) [12]51/M9.0Died, 3 years++ (20%)+ (20%)<5%nd
7Haas et al. (2007) [12]60/F4.5Alive, 1 year+ (30%)+ (50%)+ (10–20%)<2%nd
8Haas et al. (2007) [12]58/F2.3Alive+ (10%)+ (10–60%)+ (20%)5%nd
9Toriyama et al.
(2010) [13]
56/M2.2Alive, 7 months+++ (focal)+ (focal)+7.5%+ (focal)

2 tumors, each measuring 0.8 cm; +: positive; −: negative; nd: no data.